文献速递膀胱癌与上尿路尿路上皮癌

上尿路尿路上皮癌miRNA表达谱可区分肿瘤分级、分期及生存

MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making.
PubMed 文献 · Urology · 2018-10-10

本研究从两家机构157例根治性肾输尿管切除术标本中分离miRNA,评估其区分上尿路尿路上皮癌高级别与低级别、肌层浸润与非肌层浸润以及预测无复发生存和总生存的能力,发现特定miRNA组合具有较高敏感性和特异性。

要点

  • miR-29b-2-5p、miR-18a-5p、miR-223-3p和miR-199a-5p组合识别高级别UTUC的敏感性83%、特异性85%、AUC 0.86。
  • miR-10b-5p、miR-26a-5p-5p、miR-31-5p和miR-146b-5p组合预测≥pT2疾病的敏感性64%、特异性96%、AUC 0.90。
  • miR-10a-5p、miR-30c-5p和miR-10b-5p组合最佳反映RFS,miR-10a-5p、miR-199a-5p、miR-30c-5p和miR-10b-5p组合最佳预测OS。

核心结论

  • 独特miRNA特征可可靠区分高级别与低级别UTUC以及肌层浸润与非肌层浸润UTUC。
  • UTUC miRNA差异表达产生稳健的分类器预测RFS和OS,可能帮助识别最受益于辅助治疗的患者。

研究设计与样本

  • 从两家机构157例根治性肾输尿管切除术标本中分离miRNA。
  • 评估miRNA相对表达在高级别vs低级别肿瘤以及肌层浸润vs非肌层浸润肿瘤中的差异。
  • 使用特定miRNA相对表达对无复发生存(RFS)和总生存(OS)进行分层。

主要发现

  • 识别高级别UTUC的优化模型包括miR-29b-2-5p、miR-18a-5p、miR-223-3p和miR-199a-5p,敏感性83%,特异性85%,ROC曲线下面积0.86。
  • 预测≥pT2疾病的模型分类器纳入miR-10b-5p、miR-26a-5p-5p、miR-31-5p和miR-146b-5p,敏感性64%,特异性96%,曲线下面积0.90。
  • RFS最佳反映于miR-10a-5p、miR-30c-5p和miR-10b-5p组合,OS最佳预测于miR-10a-5p、miR-199a-5p、miR-30c-5p和miR-10b-5p组合。

关键数值与推荐

  • 高级别UTUC识别模型:敏感性83%,特异性85%,AUC 0.86。
  • ≥pT2疾病预测模型:敏感性64%,特异性96%,AUC 0.90。

临床怎么用

  • miRNA特征可能辅助UTUC风险分层,区分肿瘤分级和分期。
  • miRNA分类器可能预测RFS和OS,帮助筛选最受益于辅助治疗的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate microRNA (miRNA) biomarkers for upper tract urothelial carcinoma (UTUC) to improve risk stratification. METHODS: miRNA was isolated from 157 radical nephroureterectomy specimens from 2 institutions. The relative expression of miRNA was examined for high grade vs low grade tumors as well as muscle invasive vs nonmuscle invasive tumors. Recurrence free survival (RFS) and overall survival (OS) were also stratified using relative expression of specific miRNA. RESULTS: The optimized model to identify high grade UTUC included miR-29b-2-5p, miR-18a-5p, miR-223-3p, and miR-199a-5p, generating a sensitivity of 83%, specificity of 85%, and generated a receiver operating characteristic (ROC) curve with area-under-the-curve of 0.86. Similarly, the model classifier for predicting ≥pT2 disease incorporated miR-10b-5p, miR-26a-5p-5p, miR-31-5p, and miR-146b-5p, producing a sensitivity of 64%, specificity of 96%, and area-under-the-curve of 0.90. RFS was best reflected by a combination of miR-10a-5p, miR-30c-5p, and miR-10b-5p, while OS was best predicted by miR-10a-5p, miR-199a-5p, miR-30c-5p, and miR-10b-5p. CONCLUSION: High-grade vs low-grade as well as muscle invasive vs nonmuscle invasive UTUC can be reliable distinguished with unique miRNA signatures. Furthermore, differential expression of UTUC miRNA produces robust classifiers for predicting RFS and OS that may help identify patients who would most benefit from adjuvant therapies.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Browne BM, Stensland KD, Patel CK, et al. MicroRNA Expression Profiles in Upper Tract Urothelial Carcinoma Differentiate Tumor Grade, Stage, and Survival: Implications for Clinical Decision-Making. Urology. 2018. PMID: 30315887. doi:10.1016/j.urology.2018.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。